Weight Management: In a retrospective study at Memorial Sloan Kettering Cancer Center (MSKCC), patients with stage 0 to IV breast cancer on GLP-1 RAs for a median of 20 months achieved a mean weight change of 6.2 kg (95% CI, 6.2 to 2.1), which showed a 5% relative weight reduction
Peptide calculator (interactive widget) Inputs: Peptide mass in the vial: 5 mg (pre-filled) Reconstitution water volume: slider 15 ml Target dose in the study protocol (mg), typically 0.3 / 0.6 / 1.2 / 2.4 / 4.5 mg according to Lau 2021 and REDEFINE protocols Outputs: Concentration: __ mg/ml Volume per dose: __ ml Visualization of the insulin syringe: __ IU (on a 100 IU scale) Example (REDEFINE 1 CagriSema dose 2.4 mg): 5 mg + 2 ml BAC = 2.5 mg/ml = 2500 g/ml
Personal Opinion If cost were not a factor, continuous use makes the most sense based on everything we know about incretin biology
NEJMoa2301972 Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized Phase 2a trial
Because real glow isnt just about what you applyits also about what you support from within
Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium